4265 San Felipe # 1000
Houston, TX 77027

Texas Trulicity Lawsuit Attorneys

The Texas Trulicity lawsuit attorneys at Reich and Binstock have extensive experience handling legal claims against pharmaceutical giants, like Eli Lilly and Novo Nordisk. If you experienced severe side effects, stomach paralysis, GI problems, vision loss, thyroid cancer, or other severe complications from taking Trulicity or other similar GLP-1 medications, you may be entitled to significant compensation. Our Texas Trulicity lawyer group is also reviewing cases for off-label prescriptions as weight loss drugs. We aim to hold manufacturer Eli Lilly and Company responsible for prioritizing profits over consumer safety.

By pursuing most cases through class actions and filing individual lawsuits, we’re seeking maximum compensation for medical treatment costs, lost wages, pain and suffering, and other damages.

Our Texas Trulicity attorney team provides free case evaluations and handles cases on a contingency-fee basis. This means clients don’t pay anything unless we secure compensation.

If you or a loved one suffered after taking Trulicity, call 713-622-7271 or fill out our contact form to discuss your case.

Texas Trulicity lawsuit attorneys

Texas Trulicity Lawyer Team Filing Claims Nationwide

Our Texas Trulicity lawyer team handles GLP-1 drug cases across the USA. We combine decades of extensive experience in mass tort cases with a proven track record against some of the largest pharmaceutical companies in the country. Our knowledge of MDL processes allows us to position our clients’ cases for maximum settlement values. We use individualized approaches to ensure each client’s personal injuries and losses are documented.

With decades of experience, national reach, and the resources to hold drug manufacturers responsible, our Texas Trulicity law firm is the top choice for those seeking compensation and justice caused by diabetes and weight loss prescriptions.

Is There a Lawsuit Against Trulicity?

Yes, the manufacturer of Trulicity (dulaglutide) is facing lawsuits as part of the broader multidistrict litigation (MDL) against GLP-1 receptor agonist drugs. The class of medications also includes Ozempic, Wegovy, and Mounjaro. The class action lawsuits claim this class of medications caused gastroparesis and that Novo Nordisk and Eli Lilly and Company didn’t provide adequate warnings about the increased risk.

The Judicial Panel on Multidistrict Litigation created MDL No. 3094 in February 2024, consolidating legal claims in the Eastern District of Pennsylvania. Eli Lilly and Company, Trulicity’s manufacturer, is named as a defendant alongside Novo Nordisk and others.

Trulicity Lawsuit Update 2025

Texas Trulicity attorney

Over 2,000 victims have filed lawsuits in multidistrict litigation (MDL). Plaintiffs report gastrointestinal injuries such as gastroparesis and intestinal blockages caused by the GLP-1 receptor agonist. Many Trulicity patients have made allegations that Eli Lilly failed to warn about the potential risks associated with the diabetes medication.

Eli Lilly and Company received FDA approval for Trulicity (dulaglutide) in September 2014. It received FDA approval as weekly injections of GLP-1 receptor agonists to treat type 2 diabetes by maintaining blood glucose levels for adults diagnosed with type 2 diabetes. In February 2020, an indication was added to reduce the risk of cardiovascular events.

Black boxed warnings include thyroid c-cell tumors, but other warnings include increased risks of severe gastrointestinal problems, acute kidney injury from dehydration, and intestinal blockages tied to delayed stomach emptying, gastroparesis (stomach paralysis), abdominal pain, diarrhea, nausea and vomiting, as well as pulmonary aspiration.

The Food and Drug Administration (FDA) requested healthcare providers monitor renal function in patients experiencing prolonged symptoms in the gastrointestinal system. This followed numerous allegations of severe gastrointestinal issues from these diabetes medications.

Many plaintiffs’ attorneys are investigating whether manufacturers misrepresented how safe people taking Trulicity were. Lawsuits allege Eli Lilly failed to warn doctors and those taking Trulicity about the potential risk of gastroparesis, ileus, and severe gastrointestinal issues.

Dozens of new Trulicity lawsuits were filed in June and July 2025, joining MDL 3094 in the Eastern District of Pennsylvania. Plaintiffs allege serious gastrointestinal side effects such as gastroparesis, stomach paralysis, ileus, and bowel obstruction after taking Trulicity, a GLP-1 medication manufactured by Eli Lilly and Company.

In April 2024, plaintiffs filing Trulicity lawsuits report severe complications, including gastroparesis, ileus, nausea, vomiting, dehydration, and the need for emergency medical care. These injuries are linked to delayed gastric emptying caused by the drug.

Additionally, Eli Lilly and Company faced allegations of failure to disclose the known dangers of Trulicity. Plaintiffs argue that the drug manufacturer ignored growing evidence of side effects in the gastrointestinal system and did not update the Trulicity packaging accordingly.

In February 2024, the Trulicity class action lawsuit was centralized in the Eastern District of Pennsylvania, combining similar cases for those taking Ozempic, Wegovy, Mounjaro, and other drugs into one federal court. Also in February, Judge Pratter was assigned to oversee multidistrict litigation in coordination with the United States Judicial Panel on Multidistrict Litigation. After Judge Pratter died, the MDL panel appointed Judge Marston of the Eastern District of Pennsylvania to oversee cases moving forward. This single judge will oversee how parties will eventually resolve thousands of cases in the coming months.

In February 2024, Trulicity was formally added to MDL 3094 alongside other GLP-1 drugs such as Ozempic and Wegovy. Plaintiffs allege that these once-weekly injectable diabetes medications carry a heightened risk of gastrointestinal injuries.

Trulicity FDA Approval For Once-Weekly Injectable GLP-1 Receptor Agonist, Not Weight Loss Drug

Trulicity (dulaglutide) received FDA approval to treat type 2 diabetes, not as a weight loss medication. The prescription drug received FDA approval on September 18, 2014, as a once‑weekly injectable GLP‑1 receptor agonist to regulate blood sugar in adults with type 2 diabetes. In November 2022, it also received FDA approval for the treatment of type 2 diabetes in those aged 10 and older.

Trulicity is not FDA-approved as a weight loss drug or a diabetes and weight loss medication. While clinical trials like AWARD‑11 showed modest weight loss, such use remains off-label.

Trulicity is used to treat type 2 diabetes, not obesity. Trulicity patients may lose weight, but this occurs as a secondary effect. The Food and Drug Administration (FDA) doesn’t endorse use as a diabetes and weight loss medication.

Who is Eligible to File a Trulicity Lawsuit in Texas?

Texas Trulicity lawyer

Qualifying medical conditions listed on Trulicity’s Plaintiff’s Fact Sheet include the following conditions:

  • Gastroparesis

  • Abdominal pain, indigestion, constipation, diarrhea, nausea, and vomiting

  • Intestinal blockage, intestinal obstruction, bowel obstruction, and ileus

  • Decreased appetite, malnutrition, and dehydration

  • Pulmonary aspiration, pulmonary embolism, and deep vein thrombosis (DVT)

  • Wernicke encephalopathy/Wernicke-Korsakoff Syndrome

  • Gallstones, gallbladder disease, cholecystitis, and gallbladder removal

  • Acute kidney injury and kidney failure

  • Pancreatitis

  • Death

If you suffered from serious side effects, contact a Texas Trulicity lawyer for a free case evaluation.

Trulicity patients eligible to file lawsuits in Texas must have documentation so that our legal team can determine eligibility and build a strong case. Evidence needed to support most cases includes:

  • Proof of Trulicity prescriptions

  • Medical records confirming diagnosis

  • Emergency room visit summaries and hospitalization records

  • Test results (gastric emptying studies, CT scans, endoscopy reports)

  • Medical records indicating when you started taking dulaglutide and when side effects caused by it started

  • List of medications before and while taking Trulicity

  • Records documenting medical treatment costs and receipts for out-of-pocket medical expenses

  • Proof of lost wages (pay stubs, employer letters, disability forms)

  • Photographs or medical documentation of feeding tubes or surgery

  • Physician notes discussing Trulicity potentially causing the medical condition

  • Death certificate or autopsy report (if filing for a deceased loved one)

If you or a loved one experienced severe side effects while taking Trulicity, a Texas Trulicity attorney can help determine if you’re eligible to file a lawsuit for Trulicity side effects.

The evidence needed to join the Trulicity class action lawsuit or other legal claims for this class of medications is the same as listed above. The injuries and evidence required are the same. Only the legal process differs.

The deadline for filing lawsuits varies by state, but for personal injury and products liability litigation in Texas, the timeframe is typically 2 years from the date when plaintiffs realize or should have known that the GLP-1 medication was the leading cause of their injuries.

An underage person has until they turn 20 years old to file a lawsuit.

If a defendant engages in fraudulent concealment, Texas courts pause the deadline until plaintiffs discover the injury and connection to the concealed facts. Courts apply this rule when drug manufacturers withhold or misrepresent known risks. This applies to allegations that Eli Lilly and Company and Novo Nordisk concealed the dangers of gastroparesis linked to Trulicity, Ozempic, Wegovy, Moujaro, and other drugs.

For fatalities, the deadline begins from the date of death. However, if the cause of injury was fraudulently concealed, the time for filing a lawsuit may be extended.

Injuries Alleged in Trulicity Lawsuits

Stomach paralysis (gastroparesis has been called Trulicity dumping syndrome by many people taking Trulicity. Gastroparesis occurs when drugs used for managing diabetes cause delayed stomach emptying to the point where food remains in the stomach for an abnormally long period. This leads to severe side effects, such as nausea, vomiting, abdominal pain, bloating, and dangerous weight loss. Gastroparesis has frequently led to patients requiring hospitalization multiple times. Severe gastroparesis is a primary medical problem listed in Trulicity lawsuits.

If you were diagnosed with gastroparesis, contact a Texas Trulicity lawyer from our law firm for a free case evaluation.

Ileus, intestinal blockage, and intestinal obstruction are life-threatening medical conditions reported in GLP-1 users. These medical problems all involve dangerous digestive tract disruption. When the intestines cannot move food and waste, users experience severe side effects like stomach pain, chronic vomiting, bloating, constipation, and dehydration. Frequently, these health issues escalate to full bowel obstruction that requires hospitalization, surgery, or long-term medical treatment. Because GLP-1 receptor agonists slow digestion, plaintiffs argue that the medication’s manufacturer didn’t give enough warnings about the severity of intestinal obstruction and ileus.

If you suffered from intestinal obstruction, bowel obstruction, intestinal blockage, or ileus after taking Trulicity, contact a Texas Trulicity lawyer for a free case review.

One of the recognized complications of GLP-1 use is severe dehydration from diarrhea and vomiting. This has led to kidney injuries, fainting, and repeated hospitalizations. If you suffered dehydration and have expenses related to emergency room visits, prolonged IV treatments, organ damage, or long-term health issues, taking legal action may be appropriate. Call a Texas Trulicity lawsuit attorney to see if you qualify for seeking compensation.

Pancreatitis is a dangerous health issue. Acute cases may require emergency medical care for vomiting. Chronic cases can lead to permanent digestive medical problems, malnutrition, and irreversible damage to the pancreas. If you had to be hospitalized or have a diagnosis confirming damage to your pancreas, consult an attorney to discuss pursuing a Trulicity lawsuit in Texas.

Gallstones can quickly escalate to gallbladder disease. Blockages in the intestines may trigger inflammation and dangerous infections that can spread to the bloodstream. Many patients require emergency gallbladder removal, and even then, some users are left with permanent health problems or post-cholecystectomy complications that interfere with daily life. If you suffered these medical problems after using GLP-1 medications, contact our Texas Trulicity lawyers for a free case review to determine if you can pursue a Trulicity lawsuit.

Another serious Trulicity side effect is acute kidney injury and kidney failure. This frequently develops when chronic vomiting or diarrhea leads to severe dehydration and reduced blood flow to the kidneys. These severe side effects result in significant declines in kidney function. Many users have to be hospitalized or suffer permanent renal damage. If you have no prior history of renal disease and experienced severe side effects, like kidney damage or kidney failure, contact a Texas Trulicity lawsuit attorney from our law firm for a free case evaluation.

Texas Trulicity class action lawsuit attorneys

Personal Injury Outside the Scope of Trulicity Multidistrict Litigation (MDL 3094): Separate Trulicity Lawsuit Claims

You may be able to sue for thyroid cancer or C-cell tumors while taking Trulicity if your medical records indicate your diagnosis was caused by Trulicity (dulaglutide). Research has examined associations between receptor agonists and thyroid malignancies. The medication itself carries an FDA-mandated boxed warning about an increased risk of thyroid C-cell tumors. For success, Trulicity patients need medical records confirming they took Trulicity and their cancer diagnosis. Consult a Texas Trulicity attorney for a free case review to discuss your case.

Trulicity patients may be eligible to sue for pancreatic cancer if medical records confirm they were diagnosed after taking Trulicity to manage type 2 diabetes. The EMA required a study on adults taking dulaglutide and pancreatic cancer. Furthermore, the AWARD-2 trial case reports of acute pancreatitis in those taking dulaglutide. For success, you’ll need medical records indicating you were taking Trulicity and your pancreatic cancer diagnosis. Contact a Texas Trulicity lawyer for a free case evaluation to discuss taking legal action.

You may be eligible to take legal action if you developed blood clots, pulmonary embolism, or deep vein thrombosis (DVT) after taking Trulicity, particularly if medical records and expert testimony can establish a tie to the GLP-1 drug. A study on GLP-1 receptor agonists and venous thromboembolism, and a case report linking cerebral venous thrombosis to adults taking dulaglutide in both cases. For success, you’ll need medical records showing you were taking Trulicity and showing your blood clot, pulmonary embolism, or deep vein thrombosis diagnosis. For assistance with a legal claim, contact a Texas Trulicity lawyer from our legal team.

You may consider taking legal action if you developed hypoglycemia while taking Trulicity, especially if the condition required hospitalization or caused lasting harm. A study of those taking dulaglutide confirms cases of hypoglycemia. A review published by American Family Physician documents measurable risk, particularly when the drug is combined with insulin or sulfonylureas to manage diabetes. You may be eligible to pursue a Trulicity lawsuit if your medical records show you took the prescription drug and had hypoglycemia episodes. For a free case review, contact a Texas Trulicity lawyer from our law firm.

You may have grounds to take legal action if you developed vision loss or NAION after taking Trulicity or other GLP-1 drugs. You’ll need medical records indicating you were diagnosed with vision loss and that you took Trulicity. A study tied GLP-1 drugs to a higher risk of NAION. Another 5-year study confirmed over double the risk for those taking dulaglutide.

If you experienced this serious side effect, consult a Texas Trulicity lawsuit attorney from our law firm for a free case evaluation.

Allegations Against Trulicity Manufacturer Eli Lilly and Company

Eli Lilly is accused of not disclosing adequate warnings about serious gastrointestinal side effects tied to Trulicity and other GLP-1 medications. Plaintiffs allege that the company downplayed the “nature, duration, extent, and seriousness” of these heightened risks, despite concerns, complaints, and studies indicating otherwise.

Plaintiffs have argued that manufacturers engaged in concealment of adverse data by failing to disclose the full scope of risk of gastrointestinal issues as detailed in multidistrict litigation. The MDL covers allegations of fraudulent misrepresentation and negligent marketing tied to GLP-1 drugs like Trulicity. Recent coverage further describes how Trulicity patients accuse the manufacturer of downplaying common side effects tied to the drug.

Trulity wasn’t approved as a weight loss medication. Doctors may be held responsible when they prescribe medications used to treat diabetes as a weight loss drug. Recent reports show that semaglutide, a prescription drug prescribed as a weight loss medication, is tied to more hospitalizations and fatalities.

This raised concerns over whether physicians exercised care in prescribing compounded or unregulated versions of GLP-1 drugs. When medical organizations issue warnings, such as the IMA’s statement that misuse and negligent prescriptions for weight-loss drugs like Trulicity, Ozempic, Wegovy, and Mounjaro pose increased risks for those not diagnosed with type 2 diabetes. Doctors may face liability if they ignore warnings and a patient experiences serious health problems.

For these cases, liability focuses on whether the doctor followed accepted practices within the medical community by prescribing a drug approved for managing diabetes as a weight loss medication to Trulicity patients.

If you experienced severe side effects, severe pain, illnesses, or lost a loved one, contact a Texas Trulicity attorney to determine if you qualify for seeking compensation. Our Texas malpractice attorneys provide free case reviews to discuss your legal options.

Texas Trulicity law firm

Potential Trulicity Lawsuit Settlement Values and Average Class Action Lawsuit Payout Per Person

The GLP-1 Products Liability Litigation No. 3094 is active in the Eastern District of Pennsylvania but has no approved settlement program yet. Legal teams with extensive experience in pharmaceutical cases estimate the case may be settled for over $2 billion.

Estimated ranges per plaintiff include:

  • Less severe side effects (nausea, vomiting, emergency medical care): $50,000 – $150,000
  • Mild to moderate health issues (pancreatitis, gallbladder removal): $100,000 – $300,00
  • Moderate health problems (gastroparesis, multiple emergency room visits): $150,000 – $500,000
  • Severe side effects (gastroparesis with complications, ileus surgery): $300,000 – $700,000
  • Vision loss or NAION (irreversible blindness): $500,000 – $1,000,000+
  • Wrongful death: $400,000 – $1,000,000+

Call a Texas pharmaceutical injury attorney from our law firm to discuss your legal claim.

Trulicity Settlement Payout Process

Courts use established MDL mechanisms for assigning pay. This uses a points or matrix system tied to verified medical records, producing individualized offers. Courts oversee assessments and orders before distributions. From here, courts identify liens and reimbursements for medical attention before releasing payments.

Our Texas Trulicity lawyer team plays a crucial role in increasing GLP-1 drug settlement offers by proving that taking Trulicity, taking Ozempic, or taking another GLP-1 medication caused your medical condition or led to your being hospitalized. We front your expenses to leverage expert testimony, calculate medical expenses and other out-of-pocket costs, and push for punitive damages.

Our Texas Trulicity attorneys also use prior court awards and the threat of trials to pressure drug makers and their insurers to settle with our clients fairly. By consolidating cases in multidistrict litigation, our Trulicity lawsuit attorneys ensure clients benefit from consistent frameworks that often settle for larger payouts than individual cases.

Our Trulicity law firm fights to secure maximum compensation for consumers. If you want to pursue legal action, contact our attorneys for a free case review.

Other GLP-1 Drug Legal Claims We Handle

Our Texas GLP-1 drug injury lawyers also handle the following legal claims:

Contact a Texas Trulicity Attorney For a Free Consultation

As the MDL evolves over the next few weeks, the core of these cases is the active ingredient designed to mimic the GLP-1 hormone, which aids the body by pushing food more slowly through the stomach, small intestine, and large intestine. While it helps some patients, others suffer swelling, irritation, fever, or even organ complications affecting the liver, kidneys, lungs, and muscles, leaving them unable to work and facing financial losses.

Under these circumstances, pharmaceutical manufacturers have an obligation to inform patients of heightened risks rather than provide false assurances. Federal courts must address common questions about whether the brand met that duty. Factors such as how the body adjusts over weeks of use, the intended effects, and the inability of patients to retain normal health will be central to the ruling.

Our office serves patients who deserve compensation and demand accountability. If you suffered serious side effects, call a Trulicity lawsuit attorney from our law firm for a free case review.

Contact Us For a Free Legal Consultation

There is never a fee unless we recover on your behalf.
Additionally, clients are not obligated to pay expenses if a recovery is not made.

Contact Us
AWARDS & RECOGNITION